Differentially expressed genes (DEGs) between high- and low-MELK expression groups in gliomas were screened out, and the signaling pathways enriched by DEGs were identified via the gene set enrichment analysis (GSEA). The gene discussed is MELK; the disease is central nervous system cancer.